Cara Therapeutics (CARA) ROE US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
ROE, % ? 3.38% -38.8% -52.5% -207.6% -207.6%   -994.9%  
Changes by years, y/y, % +60pp -42pp -14pp -155pp 0pp     +30.2%

Cara Therapeutics. ROE, %

Cara Therapeutics. ROE, changes, pp

Cara Therapeutics (CARA) ROE US GAAP (quarter values)

2023Q3 2023Q4 2023Q4 2024Q1 2024Q2   LTM ?
ROE, % ? -133.8% -205.9% -205.9% -411.2% -957.8%   -994.9%
Changes by years, y/y, % -86pp -153pp -153pp -352pp -858pp    
Changes by quarters, q/q, % -34pp -72pp 0pp -205pp -547pp    

Cara Therapeutics. ROE, %

Cara Therapeutics. ROE, changes, pp

Cara Therapeutics. ROE, changes, pp